Trial intelligence / Profile preview

Propiverine in children with non-neurogenic OAB

NCT00603343Phase 3Completed

Sponsor
APOGEPHA
Start
Jun 2004
Primary completion
Sep 2006
Modality
Small Molecules
01

Overview

A Phase 3 trial of propiverine in overactive bladder (OAB), urinary incontinence (UI), sponsored by APOGEPHA. Started Jun 2004; status: completed.

02

Drugs

propiverine
03

Conditions

overactive bladder (OAB)urinary incontinence (UI)

Beyond the preview

Go deeper on NCT00603343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00603343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call